NPS Pharmaceuticals (NPSP)

Add to Watchlists Create an Alert
15.25 +0.30  +2.01%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

NPS Pharmaceuticals Cash from Financing Quarterly:

1.658M for Dec. 31, 2012
View Full Chart

NPS Pharmaceuticals Cash from Financing Quarterly Chart

    NPS Pharmaceuticals Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 1.658M
    Sept. 30, 2012 0.391M
    June 30, 2012 0.188M
    March 31, 2012 0.324M
    Dec. 31, 2011 1.23M
    Sept. 30, 2011 -5.809M
    June 30, 2011 98.67M
    March 31, 2011 -4.088M
    Dec. 31, 2010 -15.98M
    Sept. 30, 2010 25.27M
    June 30, 2010 38.70M
    March 31, 2010 29.39M
    Dec. 31, 2009 -14.61M
    Sept. 30, 2009 -13.87M
    June 30, 2009 4.553M
    March 31, 2009 -12.49M
    Dec. 31, 2008 -16.36M
    Sept. 30, 2008 -11.76M
    June 30, 2008 -8.746M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    NPSP Cash from Financing Quarterly Benchmarks

    Companies
    ACADIA Pharmaceuticals 91.23M
    Vertex Pharmaceuticals -6.135M
    United Therapeutics Corporation 0.694M

    NPSP Cash from Financing Quarterly Rankings

    Overall 85th percentile
    1192 of 8006
    Sector 76th percentile
    159 of 686 in Healthcare
    Industry 70th percentile
    72 of 248 in Biotechnology

    NPSP Cash from Financing Quarterly Range, Past 5 Years

    Minimum -16.36M Dec 2008
    Maximum 98.67M Jun 2011
    Average 5.087M